Literature DB >> 15021948

[Treatment of MRSA infection in orthopedic surgery].

Th Mückley1, Ch Hierholzer, M Diefenbeck, G O Hofmann, V Bühren.   

Abstract

INTRODUCTION: Infection with methicillin-resistant Staphylococcus aureus (MRSA) remains a major challenge both therapeutically and hygienically.
METHODS: Between January 2000 and January 2002, 27 patients with MRSA infections were treated and evaluated in a prospective clinical study. For effective wound management, operative revisions were performed every 3rd day. Following debridement, the wounds were vacuum sealed and specific i.v. antibiotics were administered. Wound closure was performed if three consecutive wound samples submitted for bacterial culture remained negative.
RESULTS: All patients with MRSA infections were treated successfully until signs of infection disappeared and bacterial cultures were negative. An average of 7.3 operations per patient was required to eradicate MRSA infection. Follow-up of patients revealed recurrence of infection in four patients.
CONCLUSION: Prevention of further spreading and successful treatment of MRSA infections in reconstructive orthopedic surgery is possible with appropriate surgical and hygienic concepts. In almost every second patient complex revision procedures were required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021948     DOI: 10.1007/s00104-003-0753-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  28 in total

1.  [MRSA as a challenge to clinical organization].

Authors:  F Daschner; V Schumpelick
Journal:  Chirurg       Date:  2002-09       Impact factor: 0.955

2.  Use of antibiotic-bonded grafts in vascular graft infection.

Authors:  G Torsello; W Sandmann
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-12       Impact factor: 7.069

Review 3.  Methicillin-resistant Staphylococcus aureus.

Authors:  T Young
Journal:  J Wound Care       Date:  1996-11       Impact factor: 2.072

4.  [Nosocomial infections with methicillin-resistant Staphylococcus aureus (MRSA) and epidermidis (MRSE) strains. Their importance, prophylaxis and therapy in orthopedic surgery].

Authors:  D P König; O Randerath; M H Hackenbroch
Journal:  Unfallchirurg       Date:  1999-04       Impact factor: 1.000

5.  Methicillin-resistant Staphylococcus aureus (MRSA)

Authors:  C T Keane
Journal:  Ir Med J       Date:  1993 Sep-Oct

6.  Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial.

Authors:  Z Li; R J Willke; L A Pinto; B E Rittenhouse; M J Rybak; A M Pleil; C W Crouch; B Hafkin; H A Glick
Journal:  Pharmacotherapy       Date:  2001-03       Impact factor: 4.705

7.  [Linezolid--a new antibiotic for treatment of methicillin resistant Staphylococcus aureus infections in trauma surgery? Report of 2 cases].

Authors:  A Prokop; J Isenberg; H Seifert; H M Wenchel; K E Rehm
Journal:  Unfallchirurg       Date:  2002-03       Impact factor: 1.000

8.  Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.

Authors:  C Chaix; I Durand-Zaleski; C Alberti; C Brun-Buisson
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

9.  The impact of MRSA on vascular surgery.

Authors:  A Nasim; M M Thompson; A R Naylor; P R Bell; N J London
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-09       Impact factor: 7.069

Review 10.  Postoperative wound infections: risk factors and role of Staphylococcus aureus nasal carriage.

Authors:  T M Perl; M C Roy
Journal:  J Chemother       Date:  1995-07       Impact factor: 1.714

View more
  1 in total

1.  [Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice].

Authors:  M Haenle; A Podbielski; M Ellenrieder; R Skripitz; K Arndt; W Mittelmeier; R Bader; H Gollwitzer
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.